GPT and metabolic dysfunction-associated steatotic liver disease: In a meta-analysis of 417 NAFLD patients in nine clinical randomized studies, metformin was shown to improve alanine aminotransferase (ALT), aspartate aminotransferase (AST) and body mass index (BMI) to some extent, but not in histological responses [20].